NCI, NIH directors say time is ripe for cancer ‘moonshot’

John Gregory | May 13, 2016 | Health Imaging | Cardiac Imaging

President Obama’s “moonshot” initiative on finding a cure for cancer is coming at the right time, according to a letter written by the directors of the National Institutes of Health and National Cancer Institute to be published in the New England Journal of Medicine.

For more on where they see opportunities and the challenges within the initiative, click on the link below:

Aiming High — Changing the Trajectory for Cancer

John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular Business

Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.

Cardiovascular Business

Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business

‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

NCI, NIH directors say time is ripe for cancer ‘moonshot’

Related Content

Around the web